Business · 28/12/2020Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Sesame Allergen Guidance
Summary
The FDA is extending the comment period for its draft guidance on voluntary disclosure of sesame as an allergen, in response to requests for an extension, to allow more time for industry comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →